Cross-site Scripting in DEXMA DEXGate
13Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 5.4epss 0.3%
exploitation probability
0.3%top 77% of all CVEs
observed exploitation
nono source reports it
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
Affected products
DEXMA · DexGate